<DOC>
	<DOCNO>NCT00089206</DOCNO>
	<brief_summary>RATIONALE : Vaccines may make body build immune response kill tumor cell . PURPOSE : This phase II trial study well vaccine therapy work treat patient stage III stage IV melanoma remove surgery .</brief_summary>
	<brief_title>Vaccine Therapy Treating Patients With Stage III Stage IV Melanoma That Can Be Removed By Surgery</brief_title>
	<detailed_description>OBJECTIVES : - Determine antitumor immune response patient unresectable stage III IV melanoma treat vaccine comprise multiple synthetic melanoma peptide , sargramostim ( GM-CSF ) , Montanide ISA-51 . OUTLINE : Patients receive vaccine comprise multiple synthetic melanoma peptide , sargramostim ( GM-CSF ) , Montanide ISA-51 day 1 , 8 , 15 , 29 , 36 , 43 . Patients undergo removal lymph node drain vaccination site day 22 ass immune response . PROJECTED ACCRUAL : A maximum 29 patient accrue study .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Uveal Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Freund 's Adjuvant</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis melanoma Unresectable stage III IV disease Mucosal ocular disease allow Positive HLAA1 , A2 , A3 expression PATIENT CHARACTERISTICS : Age 12 Performance status ECOG 01 Life expectancy Not specify Hematopoietic Absolute neutrophil count &gt; 1,000/mm^3 Platelet count &gt; 100,000/mm^3 Hemoglobin &gt; 9 g/dL Hepatic Liver function test ≤ 2.5 time upper limit normal ( ULN ) Renal Creatinine ≤ 1.5 time ULN Cardiovascular No New York Heart Association class III IV heart disease Other Weight ≥ 100 pound Not pregnant nursing No malignancy within past 5 year except squamous cell basal cell skin cancer without know metastasis , carcinoma situ breast , carcinoma situ cervix PRIOR CONCURRENT THERAPY : Biologic therapy No prior vaccination peptide use protocol More 1 year since prior melanoma vaccine therapy More 4 week since prior immunotherapy More 4 week since prior growth factor More 4 week since prior allergy shot Chemotherapy More 4 week since prior chemotherapy Endocrine therapy More 4 week since prior steroid therapy Radiotherapy More 4 week since prior radiotherapy Surgery Prior tumor resection allow</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>stage III melanoma</keyword>
	<keyword>stage IV melanoma</keyword>
	<keyword>recurrent melanoma</keyword>
	<keyword>recurrent intraocular melanoma</keyword>
	<keyword>iris melanoma</keyword>
	<keyword>extraocular extension melanoma</keyword>
	<keyword>ciliary body choroid melanoma , medium/large size</keyword>
</DOC>